Arvinas, Inc. (ARVN) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $10.55 (+6.62%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 18, 2026 | Srikripa Devarakonda | Truist Financial | $10.00 | -5.2% |
| Oct 30, 2025 | Jeet Mukherjee | BTIG | $14.00 | +32.7% |
| Sep 18, 2025 | Sudan Loganathan | Stephens | $14.00 | +32.7% |
| Jun 2, 2025 | Andrew Fein | H.C. Wainwright | $24.00 | +127.4% |
| May 5, 2025 | Srikripa Devarakonda | Truist Financial | $11.00 | +4.2% |
| May 2, 2025 | Jeet Mukherjee | BTIG | $16.00 | +51.6% |
| Mar 12, 2025 | Etzer Darout | BMO Capital | $20.00 | +89.5% |
| Mar 12, 2025 | Derek Archila | Wells Fargo | $26.00 | +146.4% |
| Dec 10, 2024 | Jeet Mukherjee | BTIG | $69.00 | +553.9% |
| Nov 19, 2024 | Christopher Liu | Leerink Partners | $62.00 | +487.5% |
| Oct 31, 2024 | Matthew Biegler | Oppenheimer | $40.00 | +279.0% |
| Oct 21, 2024 | Bradley Canino | Stifel Nicolaus | $63.00 | +497.0% |
| May 16, 2024 | Matthew Biegler | Oppenheimer | $70.00 | +563.3% |
| Apr 12, 2024 | Andrew Fein | H.C. Wainwright | $87.00 | +724.4% |
| Apr 11, 2024 | Bradley Canino | Stifel Nicolaus | $72.00 | +582.3% |
| Dec 19, 2023 | Derek Archila | Wells Fargo | $63.00 | +497.0% |
| Oct 23, 2023 | Robert Driscoll | Wedbush | $24.00 | +127.4% |
| Nov 22, 2022 | Edward Tenthoff | Piper Sandler | $81.00 | +667.6% |
| Feb 18, 2022 | Robert Driscoll | Wedbush | $98.00 | +828.7% |
| Feb 9, 2022 | Derek Archila | Wells Fargo | $98.00 | +828.7% |
Top Analysts Covering ARVN
ARVN vs Sector & Market
| Metric | ARVN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.09 | 2.24 | 2.41 |
| Analyst Count | 11 | 8 | 18 |
| Target Upside | +23.2% | +1150.2% | +14.9% |
| P/E Ratio | -8.21 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $14M | $34M | $72M | 10 |
| 2026-09-30 | $5M | $19M | $49M | 5 |
| 2026-12-31 | $6M | $23M | $58M | 5 |
| 2027-03-31 | $7M | $24M | $62M | 5 |
| 2027-06-30 | $7M | $25M | $64M | 5 |
| 2027-09-30 | $8M | $27M | $69M | 5 |
| 2027-12-31 | $8M | $28M | $72M | 5 |
| 2028-12-31 | $161M | $161M | $161M | 10 |
| 2029-12-31 | $90M | $209M | $378M | 5 |
| 2030-12-31 | $120M | $277M | $502M | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-1.39 | $-0.69 | $0.54 | 10 |
| 2026-09-30 | $-2.77 | $-0.92 | $-0.06 | 4 |
| 2026-12-31 | $-2.73 | $-0.91 | $-0.06 | 4 |
| 2027-03-31 | $-2.76 | $-0.92 | $-0.06 | 4 |
| 2027-06-30 | $-2.86 | $-0.95 | $-0.06 | 4 |
| 2027-09-30 | $-2.60 | $-0.87 | $-0.06 | 4 |
| 2027-12-31 | $-2.55 | $-0.85 | $-0.06 | 4 |
| 2028-12-31 | $-3.75 | $-2.14 | $2.83 | 8 |
| 2029-12-31 | $-3.84 | $-1.87 | $-0.49 | 6 |
| 2030-12-31 | $-1.29 | $-0.63 | $-0.17 | 6 |
Frequently Asked Questions
What is the analyst consensus for ARVN?
The consensus among 11 analysts covering Arvinas, Inc. (ARVN) is Buy with an average price target of $12.50.
What is the highest price target for ARVN?
The highest price target for ARVN is $125.00, set by Edward Tenthoff at Piper Sandler on 2021-08-05.
What is the lowest price target for ARVN?
The lowest price target for ARVN is $10.00, set by Srikripa Devarakonda at Truist Financial on 2026-03-18.
How many analysts cover ARVN?
11 analysts have issued ratings for Arvinas, Inc. in the past 12 months.
Is ARVN a buy or sell right now?
Based on 11 analyst ratings, ARVN has a consensus rating of Buy (2.09/5) with a +23.2% upside to the consensus target of $12.50.
What are the earnings estimates for ARVN?
Analysts estimate ARVN will report EPS of $-0.69 for the period ending 2026-06-30, with revenue estimated at $34M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.